Literature DB >> 3307785

Characterization of a cytochrome P450 deficient mutant of Candida albicans.

M Bard, N D Lees, R J Barbuch, D Sanglard.   

Abstract

A previously described Candida albicans nystatin resistant mutant blocked in 14 alpha-demethylation of lanosterol was shown to also lack all traces of cytochrome P450 as determined by carbon monoxide difference spectra. This strain does not require ergosterol for growth and reverted to an ergosterol producing, cytochrome P450 containing strain indicating no other lesions. Cytochrome P450 mutants described in Saccharomyces cerevisiae are auxotrophic for ergosterol or contain a second mutation in 5,6 desaturation of the sterol B ring. These results suggest that a cytochrome P450 lesion in these yeasts have different phenotypes and may reflect different sterol requirements for the two organisms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3307785     DOI: 10.1016/0006-291x(87)91000-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Acetate-mediated growth inhibition in sterol 14alpha-demethylation-deficient cells of Candida albicans.

Authors:  O Shimokawa; H Nakayama
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

2.  Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans.

Authors:  N D Lees; M C Broughton; D Sanglard; M Bard
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

Review 3.  Genetics of Candida albicans.

Authors:  S Scherer; P T Magee
Journal:  Microbiol Rev       Date:  1990-09

4.  Estimation of minimum sterol 14alpha-demethylation-inhibitory concentration of azoles in Candida yeasts using acetate-mediated growth inhibition: potential utility in susceptibility testing.

Authors:  O Shimokawa; H Nakayama
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

5.  Sterol synthesis and viability of erg11 (cytochrome P450 lanosterol demethylase) mutations in Saccharomyces cerevisiae and Candida albicans.

Authors:  M Bard; N D Lees; T Turi; D Craft; L Cofrin; R Barbuch; C Koegel; J C Loper
Journal:  Lipids       Date:  1993-11       Impact factor: 1.880

6.  Comparison of sterol import under aerobic and anaerobic conditions in three fungal species, Candida albicans, Candida glabrata, and Saccharomyces cerevisiae.

Authors:  Martin Zavrel; Sam J Hoot; Theodore C White
Journal:  Eukaryot Cell       Date:  2013-03-08

7.  Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents.

Authors:  Dominique Sanglard; Françoise Ischer; Tania Parkinson; Derek Falconer; Jacques Bille
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

8.  Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility.

Authors:  A Geber; C A Hitchcock; J E Swartz; F S Pullen; K E Marsden; K J Kwon-Chung; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

Review 9.  The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn.

Authors:  Quan-Zhen Lv; Lan Yan; Yuan-Ying Jiang
Journal:  Virulence       Date:  2016-05-24       Impact factor: 5.882

10.  Defined anaerobic growth medium for studying Candida albicans basic biology and resistance to eight antifungal drugs.

Authors:  Raluca Dumitru; Jacob M Hornby; Kenneth W Nickerson
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.